Weather New York, NY +70°F

Mylan Inc

Valeant Pharmaceuticals International Inc.

Valeant to drop deal-making in near term to cut debt, boost stock

Valeant Pharmaceuticals International Inc (VRX.TO) is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a stronger position, people familiar with the matter told Reuters.

Read Full Article
Abbott Laboratories Logo at their headquarters

Abbott, Mylan silent on why changing tax-inversion terms

Drugmakers Abbott Laboratories (ABT.N) and Mylan Inc (MYL.O) on Wednesday declined to explain in detail why they changed the terms of a $5.3 billion deal in which Mylan will buy part of Abbott's overseas generics business and reincorporate for tax purposes in the Netherlands.

Read Full Article
India

Mylan’s US$1.6 Billion Deal Put On Hold

Mylan’s acquisition of a unit at Strides Arcolab Ltd announced July 8 was deferred by Indian regulators.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics